Aurora Spine Corporation Announces Newly Published Paper on First 6-month Clinical Evaluation of its ZIP™ Fusion Implant
CARLSBAD, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB:ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the publication of the first 6-month clinical evaluation of its ZIP™ fusion implant in the Journal of Pain Research.
Related news for (ASAPF)
- Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System
- Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
- Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
- Aurora Spine Corporation Announces Record First Quarter Financial Results
- Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results